Molecular BiologybioRxivPreprint
A unified in vitro to in vivo fluorescence lifetime screening platform yields amyloid β aggregation inhibitors
Súil Collins, Liisa van Vliet, Fabrice Gielen…·Gabriele S. Kaminski Schierle
The paper develops a unified in vitro to in vivo fluorescence lifetime screening platform to identify amyloid β aggregation inhibitors, revealing a new compound effective in multiple models.
2 citations